RAY1225
Evaluation of RAY1225 in Adult Participants Who Have Obesity or Are Overweight
Guangdong Raynovent Biotech Co · Phase 3 · Recruiting · Enrollment 640
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| RAY1225 High Dose | Obesity or overweight | n/r | n/r | n/r | n/r |
| RAY1225 Medium Dose | Obesity or overweight | n/r | n/r | n/r | n/r |
| RAY1225 Low Dose | Obesity or overweight | n/r | n/r | n/r | n/r |
| Placebo | Obesity or overweight | n/r | n/r | n/r | n/r |